Car.70/il15-transduced cb-nk cells
WebComplete: 2024-08-31. Brief Summary. To determine the safety, efficacy and optimal cell dose of CAR 5/IL15-transduced CB-NK cells in patients with relapsed/refractory T-cell malignances, mantle cell lymphoma, and chronic lymphocytic leukemia. The efficacy and optimal dose will be identified for individual diseases. Detailed Description. WebFeb 1, 2024 · Cord blood (CB) offers an attractive, allogeneic, off-the-self source of NK cells for immunotherapy. We transduced CB-derived NK cells with a retroviral vector incorporating the genes for CAR-CD19, IL-15 and inducible caspase-9-based suicide gene (iC9), and demonstrated efficient killing of CD19-expressing cell lines and primary …
Car.70/il15-transduced cb-nk cells
Did you know?
WebAug 14, 2024 · Over 70% of human cancers upregulate NKG2D ligand ... Macapinlac HA, Thompson P, Basar R, et al. Use of CAR-transduced natural killer cells in CD19 … WebPhase 1 Phase 2 Phase 3 Phase 4 N/A. Start Date. Organizations. Indications. NCT05092451. Phase 1/Phase 2. 11/30/2024. University of Texas at Houston. …
WebFull Description. Primary Objective: To determine the safety, efficacy and optimal cell dose of CAR.70/IL15-transduced CB-NK cells in patients with relapse d/refractory … WebFeb 7, 2024 · NK cells were transduced with a retroviral vector expressing genes that encode anti-CD19 CAR, interleukin-15, and inducible caspase 9 as a safety switch. The …
WebApr 28, 2024 · Our group has investigated fourth-generation CB-derived CAR-transduced NK cells. ... cell survival pathways and decreased apoptosis. 70 NK-92MI cells have been modified by lentiviral transduction to express a first-generation ... (anti-CD19CAR.IL15.iCas9). Eleven heavily pretreated patients with CD19-positive cancers, … WebApr 28, 2024 · T cells engineered to express chimeric antigen receptors (CARs) have revolutionised the field of cellular therapy for cancer. Despite its success, this strategy …
WebHome Blood Stem Cell
WebCyclophosphamide, CAR.70/IL15-transduced CB-NK cells, Fludarabine phosphate Description The goal of this clinical research study is to learn about the safety of giving … pmma 膜WebWe transduced CB-derived NK cells with a retroviral vector incorporating the genes for CAR-CD19, IL-15 and inducible caspase-9-based suicide gene (iC9), and demonstrated … pmma 熱WebOct 25, 2024 · Drug: Cyclophosphamide Drug: CAR.70/IL15-transduced CB-NK cells Drug: Fludarabine phosphate. Phase 1 Phase 2. Detailed Description: Primary Objective: … bank dbs syariahWebApply to this Phase 1 & 2 clinical trial treating Advanced Renal Cell Carcinoma (aRCC), Advanced Mesothelioma, Advanced Osteosarcoma. Get access to cutting edge treatment via CAR.70/IL15-transduced CB-derived NK cells, Cyclophosphamide, Fludarabine phosphate. View duration, location, compensation, and staffing details. bank dbs terdekat jakarta baratWebPhase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances Latest version (submitted January 24, 2024) on ClinicalTrials.gov bank dbs pondok indahWebFeb 4, 2024 · The central hypothesis of this study predicts that knocking out the CISH gene in CAR-NK cells will enhance their effector function against tumor cells, much in the way that targeting PD-1 improves outcomes by removing a critical immune checkpoint in T cells. 20, 21 Our approach for combined retroviral transduction with the iC9/CAR19/IL-15 … pmma1605WebDec 7, 2024 · Notably, CAR expression was stable over time. iC9/CAR.123/IL15+ and iC9/hCAR.123/IL15+ NK cells expanded for 2 weeks showed no signs of exhaustion, such as downregulation of eomesodermin and T-bet, or upregulation of KLRG1, and exhibited a mature phenotype, similar to ex vivo expanded non-transduced NK cells (NT-NK) using … pmma372